Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Spatial modulation of RAF by RAF/MEK glue enables full-dose combination with pan-RAF inhibitor and potent RAS-mutant tumor-selective MAPK and growth inhibition.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026
Retraction Note: ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation.
Journal: Nature communications
Published: October 20, 2025
RAS mutation-specific signaling dynamics in response to paralog- and state- selective RAS inhibitors.
Journal: bioRxiv : the preprint server for biology
Published: April 01, 2025
RAS Mutation-Specific Responses to Paralog- and State-Selective RAS Inhibitors.
Journal: Molecular cancer research : MCR
Published: March 31, 2025
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4.
Journal: The EMBO journal
Published: February 06, 2024
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells.
Journal: Nature communications
Published: August 09, 2023
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Journal: Cell death and differentiation
Published: January 30, 2023
World Trade Center dust exposure promotes cancer in PTEN-deficient mouse prostates.
Journal: Cancer research communications
Published: August 01, 2022
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders.
Journal: Nature cancer
Published: September 27, 2021
ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation.
Journal: Nature communications
Published: December 17, 2020
Last Updated: 09/26/2026